Trial
NCT00003926
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Brain and Central Nervous System Tumors
Intervention
amifostine trihydrate
Why stopped
Withdrawn due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-29